Finasteride vs Minoxidil: Two Different Jobs

Finasteride acts on the hormone. The enzyme 5-alpha-reductase converts testosterone into DHT, and on a scalp prone to pattern hair loss, DHT gradually shrinks the follicles. MedlinePlus describes finasteride as treating male pattern hair loss by blocking the body's production of that hormone in the scalp. It addresses the cause of the shrinking, which is why stopping it lets the process resume.

Minoxidil acts on blood flow. It was developed as a blood-pressure medicine, and MedlinePlus describes oral minoxidil as a vasodilator that works by relaxing blood vessels. Applied to the scalp, it is used to stimulate hair growth and slow balding. MedlinePlus is plain about its limits: it does not cure baldness, it has no effect on receding hairlines, and most new hair is lost within a few months after it is stopped.

One medicine changes the hormonal signal; the other supports the follicle by a separate, vascular route. Neither one replaces the other, and that is the reason combinations exist.

Finasteride's FDA-approved form is an oral tablet taken once a day. Propecia is the brand approved for male pattern hair loss, and Proscar for an enlarged prostate. The FDA states there is no FDA-approved topical formulation of finasteride; topical finasteride, alone or combined with minoxidil, is made by compounding pharmacies.

Minoxidil for hair is usually topical. MedlinePlus describes a liquid applied to the scalp, usually twice a day. Oral minoxidil is a prescription tablet for high blood pressure, and using it for hair loss is off-label. Its cardiovascular considerations are covered on the oral minoxidil and the heart page.

The trade-offs between routes, including how much of each drug reaches the rest of the body, belong to the topical vs oral page, and this page does not repeat them.

Finasteride. The Propecia label says it lowers PSA, so any confirmed rise while taking it should be evaluated even if the number still looks normal. Anyone whose PSA is followed, including men on testosterone therapy, should make sure the clinician reading it knows. Sexual side effects such as reduced desire, ejaculation problems and erectile difficulty are listed by MedlinePlus, and the label's post-marketing reports include depression and suicidal ideation. Report any of these promptly. Finasteride and sexual side effects covers the reversibility question.

Topical minoxidil. Scalp itching, dryness, flaking and burning are the common complaints. MedlinePlus lists symptoms that need a call to your doctor straight away: swelling of the face, ankles or hands, a rapid heartbeat, chest pain, light-headedness and difficulty breathing when lying down. It also advises telling your doctor about any heart, kidney, liver or scalp disease before starting.

Oral minoxidil. MedlinePlus carries an important warning that it may increase chest pain or cause other heart problems, with regular blood-pressure checks and possibly an EKG.

• Finasteride is for men only. The Propecia label says it is not indicated for women. Women who are or may be pregnant should not handle crushed or broken tablets, because of the risk to a male fetus.
• Topical finasteride carries a transfer risk. In its 2025 alert on compounded topical finasteride, the FDA noted adverse event reports consistent with those for the oral tablets, local reactions such as irritation and burning, and a greater risk of exposing others, particularly women, through transfer of the applied product.
• Minoxidil and pregnancy. MedlinePlus advises telling your doctor if you are pregnant, planning a pregnancy or breastfeeding.
• Minoxidil and sunlight. MedlinePlus notes topical minoxidil may make skin more sensitive to the sun.

ACT 2's 4-in-1 Hair Loss Treatment is a compounded topical that combines finasteride and minoxidil with other agents, so that DHT signaling and follicular blood flow are addressed together rather than one at a time. The exact formulation is set by your clinician.

The reasoning for combining is the mechanism above: two medicines, two separate routes. The evidence is honest about its limits. The individual agents are well studied; the combination has less direct evidence behind it than its components, and a compounded preparation is not FDA-approved and has not been evaluated by the FDA for safety, effectiveness or quality. The FDA's alert on compounded topical finasteride applies to products like this, so the monitoring above applies to it too. ACT 2 makes no claim about how well the blend works.

Not all thinning is pattern hair loss. Shedding after illness or stress, low iron, thyroid problems and hormonal change in midlife can look similar, and they need a different response. Hair shedding vs thinning and ferritin and hair loss explain the difference. Women thinning in midlife should start with a hormonal assessment; see the hormones behind hair loss in women.